The technology sector is advocating this week for congressional approval of patent reform legislation that is opposed by pharmaceutical and manufacturing companies.

Software and other high-tech companies argue the legislation, which will be debated in the Senate on Wednesday, is critical to reducing patent litigation that can result in large financial penalties and hinder innovation.